JP2012065652A5 - - Google Patents

Download PDF

Info

Publication number
JP2012065652A5
JP2012065652A5 JP2011214253A JP2011214253A JP2012065652A5 JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5 JP 2011214253 A JP2011214253 A JP 2011214253A JP 2011214253 A JP2011214253 A JP 2011214253A JP 2012065652 A5 JP2012065652 A5 JP 2012065652A5
Authority
JP
Japan
Prior art keywords
cells
sendai virus
vector
cell
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011214253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012065652A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011214253A priority Critical patent/JP2012065652A/ja
Priority claimed from JP2011214253A external-priority patent/JP2012065652A/ja
Publication of JP2012065652A publication Critical patent/JP2012065652A/ja
Publication of JP2012065652A5 publication Critical patent/JP2012065652A5/ja
Pending legal-status Critical Current

Links

JP2011214253A 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法 Pending JP2012065652A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003374808 2003-11-04
JP2003374808 2003-11-04
JP2004187028 2004-06-24
JP2004187028 2004-06-24
JP2011214253A JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005515163A Division JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Publications (2)

Publication Number Publication Date
JP2012065652A JP2012065652A (ja) 2012-04-05
JP2012065652A5 true JP2012065652A5 (cg-RX-API-DMAC7.html) 2012-12-20

Family

ID=34554806

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法
JP2011214253A Pending JP2012065652A (ja) 2003-11-04 2011-09-29 遺伝子導入された樹状細胞の製造方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2005515163A Withdrawn JPWO2005042737A1 (ja) 2003-11-04 2004-10-29 遺伝子導入された樹状細胞の製造方法

Country Status (8)

Country Link
US (1) US20070269414A1 (cg-RX-API-DMAC7.html)
EP (1) EP1690937B1 (cg-RX-API-DMAC7.html)
JP (2) JPWO2005042737A1 (cg-RX-API-DMAC7.html)
KR (1) KR101279748B1 (cg-RX-API-DMAC7.html)
CN (1) CN1902312B (cg-RX-API-DMAC7.html)
AU (1) AU2004286144A1 (cg-RX-API-DMAC7.html)
CA (1) CA2544786A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005042737A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0863202T3 (da) 1995-11-01 2010-09-27 Dnavec Research Inc Rekombinant Sendai-virus
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
AU2001244675A1 (en) 2000-03-30 2001-10-08 Dnavec Research Inc. Aids virus vaccine with the use of sendai virus vector
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
WO2005001082A1 (ja) * 2003-06-30 2005-01-06 Dnavec Research Inc. 高変異領域が改変された遺伝子を搭載するマイナス鎖rnaウイルスベクター
CA2544786A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
WO2005067981A1 (ja) * 2004-01-13 2005-07-28 Dnavec Research Inc. 免疫刺激性サイトカインをコードするマイナス鎖rnaウイルスベクターを用いる腫瘍の遺伝子治療
JPWO2005097988A1 (ja) * 2004-03-23 2008-02-28 株式会社ディナベック研究所 組織の維持および／または修復に関連する骨髄関連細胞
AU2005257107A1 (en) * 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having RNA virus transferred thereinto
CA2612168A1 (en) * 2005-06-14 2006-12-21 Dnavec Corporation Methods for producing antibodies
CN101405389A (zh) * 2006-01-17 2009-04-08 生物载体株式会社 新型蛋白质表达系统
JPWO2008136438A1 (ja) * 2007-04-27 2010-07-29 国立大学法人九州大学 遺伝子治療用ウイルスベクター
CN101755045B (zh) 2007-05-17 2014-02-12 生物载体株式会社 树突状细胞的制备方法
WO2009013018A2 (en) * 2007-07-24 2009-01-29 Stichting Katholieke Universiteit Radboud University Nijmegen Medical Centre Compositions and methods for generating an immune response in a subject
WO2009028945A2 (en) * 2007-08-30 2009-03-05 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Pathways involved in arteriogenesis and uses thereof
US20120015040A1 (en) * 2008-03-03 2012-01-19 University Of Toledo Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof
US8741639B2 (en) 2008-11-14 2014-06-03 Dnavec Corporation Method for producing dendritic cells
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2020237315A1 (en) * 2019-05-31 2020-12-03 Telethon Kids Institute Immunogenic compositions

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPH084508B2 (ja) 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
JPH01285498A (ja) 1988-05-11 1989-11-16 Mitsubishi Heavy Ind Ltd 宇宙用パネル展開装置
TW232710B (cg-RX-API-DMAC7.html) 1991-09-13 1994-10-21 American Cyanamid Co
JPH05192160A (ja) 1992-01-20 1993-08-03 Banyu Pharmaceut Co Ltd Ｃ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡ及びポリペプチド
EP0619840A1 (en) 1992-10-06 1994-10-19 Akzo Nobel N.V. Pseudorabies virus vaccine
US6077519A (en) * 1993-01-29 2000-06-20 University Of Pittsburgh Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients
DE69435155D1 (de) * 1993-04-30 2008-12-04 Wellstat Biologics Corp Zusuammensetzungen zur Behandlung von Krebs mittels Viren
US5744144A (en) 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5798100A (en) 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
KR100552387B1 (ko) * 1995-10-31 2006-04-21 가부시끼가이샤 디나벡 겡뀨쇼 자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터
DK0863202T3 (da) * 1995-11-01 2010-09-27 Dnavec Research Inc Rekombinant Sendai-virus
US6734014B1 (en) * 1996-02-08 2004-05-11 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating T cells
AU1733697A (en) 1996-02-29 1997-09-16 Takara Shuzo Co., Ltd. Method of purifying and removing viruses
AU7499498A (en) * 1997-05-21 1998-12-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions for making dendritic cells from expanded populations ofmonocytes and for activating t cells
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
CA2368948C (en) 1999-05-18 2013-12-24 Dnavec Research Inc. Envelope gene-deficient virus vector of paramyxoviridae
WO2000070055A1 (en) 1999-05-18 2000-11-23 Dnavec Research Inc. Rnp originating in paramyxovirus
US20030022376A1 (en) * 1999-05-18 2003-01-30 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
EP1067179A1 (en) 1999-07-09 2001-01-10 Pierre Fabre Medicament Method to select attenuated paramyxoviridae useful for vaccines and therapeutics
US20020123479A1 (en) * 1999-12-08 2002-09-05 Song Elizabeth S. Immunostimulation mediated by gene-modified dendritic cells
US6472208B1 (en) * 1999-12-13 2002-10-29 Héma-Québec Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
AU2001244675A1 (en) * 2000-03-30 2001-10-08 Dnavec Research Inc. Aids virus vaccine with the use of sendai virus vector
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
US20050013810A1 (en) * 2001-05-08 2005-01-20 Waller Edmund K Regulating immune response using dendritic cells
JP2005505261A (ja) * 2001-07-05 2005-02-24 ファイロジックス・インコーポレーテッド 樹状細胞単離法
CN1636229B (zh) * 2001-09-06 2012-12-19 西北生物治疗药物公司 引发单核树突细胞和t细胞th-1应答的组合物和方法
KR20040039366A (ko) * 2001-09-18 2004-05-10 가부시키가이샤 디나벡크 겐큐쇼 입자 형성능이 저하된 （－）가닥 ｒｎａ 바이러스 벡터의 검사방법 및 제조방법
EP1438399A4 (en) * 2001-09-28 2005-09-14 Univ North Carolina PARAMYXOVIRES AS VECTORS FOR GENTRANSFER IN LUNG CELLS
WO2003029475A1 (fr) * 2001-09-28 2003-04-10 Dnavec Research Inc. Vecteur viral infectant une cellule de mammifere, codant pour la $g(b)2m liee a un epitope
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
WO2003102183A1 (en) * 2002-06-03 2003-12-11 Dnavec Research Inc. Pramyxovirus vectors encoding antibody and utilization thereof
AU2002951082A0 (en) * 2002-08-30 2002-09-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic cellular agents
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
WO2004053095A2 (en) * 2002-12-10 2004-06-24 Merix Bioscience, Inc. In situ maturation of dendritic cells
CA2544786A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
WO2005067981A1 (ja) * 2004-01-13 2005-07-28 Dnavec Research Inc. 免疫刺激性サイトカインをコードするマイナス鎖rnaウイルスベクターを用いる腫瘍の遺伝子治療
EP2434020B1 (en) * 2004-01-22 2014-11-05 Dnavec Research Inc. Method of producing Paramyxoviridae viral vectors using a hybrid promoter comprising a cytomegalovirus enhancer and a chicken beta-actin promoter
CA2560046A1 (en) * 2004-03-16 2005-09-22 Dnavec Research Inc. Methods for suppressing tumor proliferation
JPWO2005097988A1 (ja) * 2004-03-23 2008-02-28 株式会社ディナベック研究所 組織の維持および／または修復に関連する骨髄関連細胞
AU2005257107A1 (en) * 2004-06-24 2006-01-05 Dnavec Research Inc. Anticancer agent containing dendritic cell having RNA virus transferred thereinto
EP1891215B1 (en) * 2005-04-20 2009-10-28 Dnavec Corporation Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
EP2034014A1 (en) * 2006-05-31 2009-03-11 Dnavec Corporation Therapeutic agent for alzheimer's disease
CN101755045B (zh) * 2007-05-17 2014-02-12 生物载体株式会社 树突状细胞的制备方法

Similar Documents

Publication Publication Date Title
JP2012065652A5 (cg-RX-API-DMAC7.html)
JP2012130346A5 (cg-RX-API-DMAC7.html)
JP2016537982A5 (cg-RX-API-DMAC7.html)
JP2011125348A5 (cg-RX-API-DMAC7.html)
JP2016528894A5 (cg-RX-API-DMAC7.html)
JP2016521993A5 (cg-RX-API-DMAC7.html)
WO2013049121A3 (en) Recombinant phage and methods
JP2016501515A5 (cg-RX-API-DMAC7.html)
JP2012050449A5 (cg-RX-API-DMAC7.html)
JP2014501518A5 (cg-RX-API-DMAC7.html)
JP2013531978A5 (cg-RX-API-DMAC7.html)
JP2016518142A5 (cg-RX-API-DMAC7.html)
JP2015165823A5 (cg-RX-API-DMAC7.html)
JP2017524348A5 (cg-RX-API-DMAC7.html)
JP2016500260A5 (cg-RX-API-DMAC7.html)
JP2013516982A5 (cg-RX-API-DMAC7.html)
JP2013530680A5 (cg-RX-API-DMAC7.html)
JP2013517776A5 (cg-RX-API-DMAC7.html)
JP2014511118A5 (cg-RX-API-DMAC7.html)
IL232662B (en) Process for producing virus-like particles comprising enterobacteriophage ms2 capsid proteins
WO2013033308A3 (en) Methods for tissue culture and transformation of sugarcane
MX2021009554A (es) Produccion de virus en cultivos celulares.
JP2011162558A5 (cg-RX-API-DMAC7.html)
PH12014500640A1 (en) Increasing virus-like particle yield in plants
JP2018515089A5 (cg-RX-API-DMAC7.html)